• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓栓塞性疾病患者基于社区的抗凝监测审计:是否需要频繁检测?

Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?

作者信息

Young L, Ockelford P, Harper P

机构信息

Department of Haematology, Auckland Hospital, Auckland, New Zealand.

出版信息

Intern Med J. 2004 Nov;34(11):639-41. doi: 10.1111/j.1445-5994.2004.00690.x.

DOI:10.1111/j.1445-5994.2004.00690.x
PMID:15546458
Abstract

Oral anticoagulant monitoring is managed by general practitioners in Auckland. An audit of this service in 452 patients demonstrated that anticoagulant control was in line with recommended international guidelines, with 58.3% of international normalized ratio (INR) measurements in the therapeutic range. However, the frequency of testing was high, with the majority of patients (68%), including those on long-term treatment, having INR measurements at weekly intervals. We question the need for such frequent INR testing.

摘要

奥克兰的全科医生负责口服抗凝剂监测。对452名患者的这项服务进行的一项审计表明,抗凝控制符合推荐的国际指南,国际标准化比值(INR)测量值中有58.3%处于治疗范围内。然而,检测频率很高,大多数患者(68%),包括那些接受长期治疗的患者,每周都进行INR测量。我们质疑如此频繁进行INR检测的必要性。

相似文献

1
Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?血栓栓塞性疾病患者基于社区的抗凝监测审计:是否需要频繁检测?
Intern Med J. 2004 Nov;34(11):639-41. doi: 10.1111/j.1445-5994.2004.00690.x.
2
Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.华法林治疗稳定患者亚治疗剂量抗凝的血栓栓塞后果:低国际标准化比值(INR)研究
Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.
3
The impact of pharmacist-managed oral anticoagulation therapy in older veterans.药剂师管理的口服抗凝治疗对老年退伍军人的影响。
J Clin Pharm Ther. 2007 Feb;32(1):21-9. doi: 10.1111/j.1365-2710.2007.00792.x.
4
[Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
Duodecim. 1998;114(6):573-5.
5
In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation.机械心脏瓣膜植入术后住院患者国际标准化比值自我检测指南
Ann Thorac Surg. 2008 Jun;85(6):2046-50. doi: 10.1016/j.athoracsur.2008.01.051.
6
Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
Int J Lab Hematol. 2008 Dec;30(6):531-5. doi: 10.1111/j.1751-553X.2007.00995.x.
7
Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.国际标准化比值在监测狼疮抗凝物患者华法林治疗中的不可靠性。
Pharmacotherapy. 2004 Jul;24(7):838-42. doi: 10.1592/phco.24.9.838.36102.
8
Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.起始剂量为每日5毫克的华法林诱导治疗是安全的,抗凝药物过量风险较低:一项针对开始使用华法林的深静脉血栓形成患者的审计结果。
Intern Med J. 2005 Dec;35(12):717-20. doi: 10.1111/j.1445-5994.2005.00973.x.
9
Management of oral anticoagulant treatment in patients with venous thromboembolism.静脉血栓栓塞症患者的口服抗凝治疗管理
Semin Thromb Hemost. 2006 Nov;32(8):781-6. doi: 10.1055/s-2006-955460.
10
Performance improvement in managed long-term care: improving warfarin medication management.管理式长期护理中的绩效改进:改善华法林药物管理
Home Healthc Nurse. 2009 Mar;27(3):150-9. doi: 10.1097/01.NHH.0000347679.23241.18.

引用本文的文献

1
An audit of anticoagulant management to assess anticoagulant control using decision support software.一项使用决策支持软件评估抗凝控制的抗凝管理审计。
BMJ Open. 2014 Sep 2;4(9):e005864. doi: 10.1136/bmjopen-2014-005864.
2
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.口服直接凝血酶抑制剂 AZD0837 预防非瓣膜性心房颤动患者的中风和全身性栓塞:一项随机剂量指导、安全性和耐受性研究,比较 AZD0837 与维生素 K 拮抗剂的四种剂量。
Eur Heart J. 2009 Dec;30(23):2897-907. doi: 10.1093/eurheartj/ehp318. Epub 2009 Aug 18.